Our current groups include: Africa, Middle East, Central Asia Network, African American Network, Chinese Culture Network, Early Career Professionals, Japanese International Leadership Network (JILN), Lilly India Network, Organization of Latinos at Lilly, PRIDE (LGBTQ + Allies), Veterans Leadership Network, Women’s Network, Working and Living with Disabilities. Sigilon Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is developing an implanted cellular product composed of an active cell component encapsulated within alginate hydrogel spheres for the treatment of type 1 diabetes.